We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Barbara Karp

Barbara I. Karp MD

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Barbara Illowsky Karp, MD, received her undergraduate degree and a Master's in biochemistry from MIT and MD from the Columbia University College of Physicians and Surgeons. She then moved to the DC area for internship, residency in neurology at the George Washington Medical Center and fellowship in behavioral neurology at the NIH.  She served as Chief of the NIH/NINDS Neurology Consultation Service and then established the multi-institute NIH Combined NeuroScience IRB, serving as its chair.  In 2019 she joined the NINDS Division of Clinical Research.  Her clinical practice and research have focused on movement disorders and therapeutic applications of botulinum toxin.

Disclosures

Dr. Karp is the Principal Investigator on a clinical trial of botulinum toxin for chronic pelvic pain for which NIH received toxin and funds for study monitoring from Allergan, Inc. She has been a co-investigator on other studies for which NIH received funds from Allergan and Merz.

Recent Contributions to PracticeUpdate:

  1. Botulinum Neurotoxin Injection for Dystonic Hand Tremor